Dendritic cell-activated cytokine-induced killer cells - Shanghai Jia Fu MedicalAlternative Names: Autologous dendritic cell cytokine-induced killer cell therapy - Shanghai Jia Fu Medical; DC CIK biotherapy - Shanghai Jia Fu Medical Apparatus; DC-activated CIK - Shanghai Jia Fu Medical Apparatus; DC-CIK - Shanghai Jia Fu Medical Apparatus; DCIK - Shanghai Jia Fu Medical Apparatus; Dendritic cell cytokine-induced killer cell therapy - Shanghai Jia Fu Medical
Latest Information Update: 18 Jul 2012
At a glance
- Originator Shanghai Jia Fu Medical Apparatus
- Class Cell therapies; Dendritic cell vaccines
- Mechanism of Action Cytokine induced killer cell modulators; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Cancer
Most Recent Events
- 13 Jul 2012 Product launched for Cancer (Parenteral) before July 2012